Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × decitabine and cedazuridine drug combination × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 5 Myeloproliferative Disorders 3 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Chronic 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Hodgkin Disease 1 GATA2 Deficiency 1 Carcinoma, Merkel Cell 1 Anemia, Refractory, with Excess of Blasts 1 Allogeneic Stem Cell Transplantation 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

pembrolizumab 26 Cisplatin 21 Cetuximab 19 Carboplatin 18 Magnetic Resonance Spectroscopy 12 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Paclitaxel 8 Radiotherapy 7 Platinum 7 Nivolumab 7 Fluorouracil 7 Docetaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 5 Ipilimumab 4 atezolizumab 3 Taxes 3 Radiosurgery 3 Immunoglobulin G 3 Fulvestrant 3 Drug Therapy 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 dehydroftorafur 2 cemiplimab 2 Surgical Procedures, Operative 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡